Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, November 1998, p. 2938-2942, Vol. 42, No. 11
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Fluconazole versus Candida albicans: A
Complex Relationship
John R.
Graybill,1,2,*
Eleanor
Montalbo,2
William R.
Kirkpatrick,1
Michael F.
Luther,2
Sanjay G.
Revankar,1 and
Thomas F.
Patterson1,2
Division of Infectious Diseases, The
University of Texas Health Science Center at San
Antonio,1 and
Infectious Diseases
Section, The Audie Murphy Memorial Veterans
Hospital,2 San Antonio, Texas 78284
Received 15 September 1997/Returned for modification 4 December
1997/Accepted 31 March 1998
A murine model of systemic candidiasis was used to assess the
virulence of serial Candida albicans strains for which
fluconazole MICs were increasing. Serial isolates from five patients
with 17 episodes of oropharyngeal candidiasis were evaluated. The MICs for these isolates exhibited at least an eightfold progressive increase
from susceptible (MIC < 8 µg/ml; range, 0.25 to 4 µg/ml) to
resistant (MIC
16 µg/ml; range, 16 to
128 µg/ml).
Virulence of the serial isolates from three of five patients showed a
more than fivefold progressive decrease in the dose accounting
for 50% mortality and was associated with development of fluconazole resistance. Low doses of fluconazole prolonged survival of mice infected with susceptible yeasts but failed to prolong
survival following challenge with a resistant strain. In
addition, a decreased burden of renal infection was noted in mice
challenged with two of the three resistant strains. This was consistent
with reduced virulence. Fluconazole did not further decrease the level
of infection. In the isolates with a decrease in virulence, two
exhibited overexpression of CDR, which encodes an
ABC drug efflux pump. In contrast, serial isolates from the remaining
two patients with the development of resistance did not demonstrate a
change in virulence and fluconazole remained effective in prolonging
survival, although significantly higher doses of fluconazole were
required for efficacy. Resistant isolates from both of these patients
exhibited overexpression of MDR. This study demonstrates
that decreased virulence of serial C. albicans isolates is
associated with increasing fluconazole MICs in some cases but not in
others and shows that these low-virulence strains may not consistently
cause infection.
*
Corresponding author. Mailing address: Infectious
Diseases Division (111F), Audie Murphy Memorial Veterans Hospital, 7400 Merton Minter Blvd., San Antonio, TX 78284. Phone: (210)
617-5111. Fax: (210) 614-6197. E-mail:
GRAYBILL{at}UTHSCSA.EDU.
Antimicrobial Agents and Chemotherapy, November 1998, p. 2938-2942, Vol. 42, No. 11
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sanguinetti, M., Posteraro, B., La Sorda, M., Torelli, R., Fiori, B., Santangelo, R., Delogu, G., Fadda, G.
(2006). Role of AFR1, an ABC Transporter-Encoding Gene, in the In Vivo Response to Fluconazole and Virulence of Cryptococcus neoformans. Infect. Immun.
74: 1352-1359
[Abstract]
[Full Text]
-
Prasad, T., Saini, P., Gaur, N. A., Vishwakarma, R. A., Khan, L. A., Haq, Q. M. R., Prasad, R.
(2005). Functional Analysis of CaIPT1, a Sphingolipid Biosynthetic Gene Involved in Multidrug Resistance and Morphogenesis of Candida albicans. Antimicrob. Agents Chemother.
49: 3442-3452
[Abstract]
[Full Text]
-
Lee, M.-K., Williams, L. E., Warnock, D. W., Arthington-Skaggs, B. A.
(2004). Drug resistance genes and trailing growth in Candida albicans isolates. J Antimicrob Chemother
53: 217-224
[Abstract]
[Full Text]
-
Gauthier, C., Weber, S., Alarco, A.-M., Alqawi, O., Daoud, R., Georges, E., Raymond, M.
(2003). Functional Similarities and Differences between Candida albicans Cdr1p and Cdr2p Transporters. Antimicrob. Agents Chemother.
47: 1543-1554
[Abstract]
[Full Text]
-
Arathoon, E. G., Gotuzzo, E., Noriega, L. M., Berman, R. S., DiNubile, M. J., Sable, C. A.
(2002). Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for Treatment of Oropharyngeal and Esophageal Candidiases. Antimicrob. Agents Chemother.
46: 451-457
[Abstract]
[Full Text]
-
Barchiesi, F., Calabrese, D., Sanglard, D., Falconi Di Francesco, L., Caselli, F., Giannini, D., Giacometti, A., Gavaudan, S., Scalise, G.
(2000). Experimental Induction of Fluconazole Resistance in Candida tropicalis ATCC 750. Antimicrob. Agents Chemother.
44: 1578-1584
[Abstract]
[Full Text]
-
Li, R. K., Elie, C. M., Clayton, G. E., Ciblak, M. A.
(2000). Comparison of a New Colorimetric Assay with the NCCLS Broth Microdilution Method (M-27A) for Antifungal Drug MIC Determination. J. Clin. Microbiol.
38: 2334-2338
[Abstract]
[Full Text]
-
Xiong, J., Kang, K., Liu, L., Yoshida, Y., Cooper, K. D., Ghannoum, M. A.
(2000). Candida albicans and Candida krusei Differentially Induce Human Blood Mononuclear Cell Interleukin-12 and Gamma Interferon Production. Infect. Immun.
68: 2464-2469
[Abstract]
[Full Text]
-
Ghannoum, M. A.
(2000). Potential Role of Phospholipases in Virulence and Fungal Pathogenesis. Clin. Microbiol. Rev.
13: 122-143
[Abstract]
[Full Text]
-
Ghannoum, M. A., Rice, L. B.
(1999). Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance. Clin. Microbiol. Rev.
12: 501-517
[Abstract]
[Full Text]
-
Lopez-Ribot, J. L., McAtee, R. K., Perea, S., Kirkpatrick, W. R., Rinaldi, M. G., Patterson, T. F.
(1999). Multiple Resistant Phenotypes of Candida albicans Coexist during Episodes of Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected Patients. Antimicrob. Agents Chemother.
43: 1621-1630
[Abstract]
[Full Text]